FTO mediates the diabetic kidney disease progression through regulating the m6A modification of NLRP3

We found that FTO could inhibit the DKD progression in vivo and in vitro by regulated the m<sup>6</sup>A modification of NLRP3.

Authors

Institutions

Publication Details

Journal
BMC Nephrology
Published
2024-10-10
DOI
https://doi.org/10.1186/s12882-024-03741-5
Citations
3
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FTO mediates the diabetic kidney disease progression through regulating the m6A modification of NLRP3

Qiang Li, Shujuan Mu
3 citations
BMC Nephrology
RNA modifications and cancer
0.70
article

FTO mediates the diabetic kidney disease progression through regulating the m6A modification of NLRP3

Qiang Li, Shujuan Mu
article en
3 citations

Abstract

We found that FTO could inhibit the DKD progression in vivo and in vitro by regulated the m<sup>6</sup>A modification of NLRP3.

BMC NephrologyVol. 25(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Guang’anmen Hospital (CN)
Good health and well-being
Openalex Percentile: Top 29%
RNA modifications and cancer
0.70
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.